The Importance of Sales Call Planning in Laboratory Outreach Sales - Insights
Sales is a vital component of a thriving laboratory outreach program. It requires a unique skill set and a dedicated focus on advocating the value of your laboratory and its ability to deliver reliable, high-quality services to your...
Pathways Case Studies: March 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for March include the following sub-specialties: Breast Pathology, Cytopathology,...
October 2023 - Clinical Microbiology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.
Pathways Case Studies: December 2023 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for December include the following sub-specialties: Cardiovascular Pathology and...
Operational updates - Insights
The latest operational updates from Mayo Clinic Laboratories, including holiday shipping schedules, information technology changes, and more.
Perspectives Archives - Page 2 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Archives - Page 33 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 9 - Insights
This week’s Research Roundup highlights a subset of well-differentiated hepatocellular carcinomas that are arginase-1 negative.
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 30 - Insights
This week’s Research Roundup highlights rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease.